Landscape Capital Management’s Quest Diagnostics DGX Stock Holding History

Landscape Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,950	Closed	-$1.75M	–	708
2026 Q1	$1.75M	Buy	+8,950	New	+$1.74M	0.11%	278
2025 Q1	–	Sell	-12,969	Closed	-$1.96M	–	680
2024 Q4	$1.96M	Buy	12,969 +4,188	+48%	+$651K	0.21%	140
2024 Q3	$1.36M	Buy	+8,781	New	+$1.31M	0.14%	211
2018 Q2	–	Sell	-39,479	Closed	-$3.96M	–	541
2018 Q1	$3.96M	Buy	+39,479	New	+$4.04M	0.28%	79
2016 Q4	–	Sell	-13,076	Closed	-$1.11M	–	577
2016 Q3	$1.11M	Buy	+13,076	New	+$1.1M	0.15%	111
2014 Q4	–	Sell	-3,300	Closed	-$200K	–	535
2014 Q3	$200K	Sell	3,300 -300	-8%	-$18.5K	0.14%	248
2014 Q2	$211K	Buy	+3,600	New	+$211K	0.14%	208

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Landscape Capital Management's DGX Position: Q2 2026 in Review

Landscape Capital Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 8,950 shares — an estimated $1.75M sold.

Landscape Capital Management first reported a position in DGX in Q2 2014 and held it in 7 quarters. The position peaked at $3.96M in Q1 2018. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Landscape Capital Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
Landscape Capital Management sold 8,950 Quest Diagnostics shares in Q2 2026, an estimated $1.75M.
Landscape Capital Management first reported a position in Quest Diagnostics in Q2 2014 and held it in 7 quarters.
Landscape Capital Management's Quest Diagnostics position peaked at $3.96M in Q1 2018.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.